Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs 5,427
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Pipeline programs

Page 104 of 114

  1. Ypeginterferon alfa-2b

    The First People's Hospital of Lianyungang

    Chronic Hepatitis B

    phase 3 small molecule completed

    3 trials

  2. Yutiq 0.18 MG Drug Implant

    ANI PHARMACEUTICALS INC

    Uveitis

    phase 3 small molecule active

    1 trial

  3. ZASOCITINIB

    Takeda

    Moderate to Severe Plaque Psoriasis

    phase 3 small molecule active

    1 trial

  4. ZB020-03-001

    Zenas BioPharma

    Primary Progressive Multiple Sclerosis (PPMS)

    phase 3 small molecule active

    1 trial

  5. ZB203L01

    Zambon SpA

    Motor fluctuations in advanced Parkinson’s disease

    phase 3 small molecule active

    1 trial

  6. ZD6474 (vandetanib)

    Sanofi Pasteur

    Non-Small-Cell Lung Carcinoma

    phase 3 small molecule completed

    1 trial

  7. ZILRETTA

    Pacira Ireland Limited

    Glenohumeral Osteoarthritis

    phase 3 small molecule active

    1 trial

  8. ZOSTER ICO-N-2018-14

    CERO THERAPEUTICS HOLDINGS, INC.

    Patients, men or women over 18 old, with inoperable vertebral bone metastases who must beneficit treatment with stereotactic radiotherapy

    phase 3 small molecule active

    1 trial

  9. ZP1848-23029

    Zealand Pharma A/S

    Short Bowel Syndrome

    phase 3 small molecule active

    1 trial

  10. ZWI-ZW25-301

    Jazz Pharmaceuticals Ireland Limited

    Gastroesophageal Adenocarcinoma (GEA)

    phase 3 small molecule active

    1 trial

  11. ZX008 (Fenfluramine Hydrochloride)

    International Peace Maternity and Child Health Hospital

    Dravet Syndrome

    phase 3 small molecule completed

    1 trial

  12. ZYN002 Transdermal Gel Cannabidiol (CBD)

    Harmony Biosciences Holdings

    Fragile X Syndrome (FXS)

    phase 3 small molecule active

    1 trial

  13. ZYN2-CL-033

    Harmony Biosciences Holdings

    Fragile X syndrome (FXS)

    phase 3 small molecule active

    1 trial

  14. Zanidatamab

    BEONE MEDICINES AUS PTY LTD

    Gastric Neoplasms

    phase 3 small molecule active

    1 trial

  15. Zanidatamab

    Jazz Pharmaceuticals Ireland Limited

    Biliary Tract Cancer

    phase 3 small molecule active

    1 trial

  16. Zanidatamab

    Jazz Pharmaceuticals Ireland Limited

    Metastatic HER2-positive Breast Cancer

    phase 3 small molecule active

    1 trial

  17. Zanubrutinib

    BeiGene

    Chronic Lymphocytic Leukemia

    phase 3 small molecule completed

    1 trial

  18. Zanubrutinib

    BEONE MEDICINES AUS PTY LTD

    B-cell Malignancies

    phase 3 small molecule active

    1 trial

  19. Zanubrutinib

    BEONE MEDICINES AUS PTY LTD

    Chronic Lymphocytic Leukemia

    phase 3 small molecule active

    2 trials

  20. Zanubrutinib

    BEONE MEDICINES AUS PTY LTD

    B-cell malignancies

    phase 3 small molecule active

    1 trial

  21. Zanubrutinib

    BEONE MEDICINES AUS PTY LTD

    Primary Membranous Nephropathy

    phase 3 small molecule active

    1 trial

  22. Zanubrutinib

    BEONE MEDICINES AUS PTY LTD

    Relapsed/Refractory Follicular Lymphoma

    phase 3 small molecule active

    1 trial

  23. Zanubrutinib

    BeiGene

    B-cell Malignancies

    phase 3 small molecule active

    2 trials

  24. Zasocitinib

    Takeda

    Psoriatic Arthritis

    phase 3 small molecule active

    3 trials

  25. Zasocitinib

    Takeda

    Plaque Psoriasis

    phase 3 small molecule active

    2 trials

  26. Zavegepant

    Pfizer

    Migraine

    phase 3 small molecule completed

    1 trial

  27. Ziftomenib

    Kura Oncology

    Acute Myeloid Leukemia (AML)

    phase 3 small molecule active

    1 trial

  28. Zilebesiran

    Alnylam Netherlands B.V.

    High Risk Cardiovascular Disease

    phase 3 small molecule active

    1 trial

  29. Zilovertamab vedotin

    Merck KGaA, Darmstadt, Germany

    Diffuse Large B-Cell Lymphoma

    phase 3 mab active

    1 trial

  30. Ziltivekimab

    Novo Nordisk A/S

    Heart Failure

    phase 3 small molecule active

    1 trial

  31. Zilucoplan sodium

    Lacuna Pharma Pty Ltd

    Generalized Myasthenia Gravis

    phase 3 small molecule active

    1 trial

  32. Zimberelimab

    Arcus Biosciences

    Non-small Cell Lung Cancer

    phase 3 small molecule active

    2 trials

  33. Zinc sulphate

    United Therapeutics Europe Ltd

    Diarrhea

    phase 3 other completed

    1 trial

  34. Zinc sulphate 20 mg

    United Therapeutics Europe Ltd

    Bronchiolitis

    phase 3 small molecule completed

    1 trial

  35. Ziprasidone

    Pfizer

    Bipolar Disorder

    phase 3 small molecule completed

    1 trial

  36. ZoMaxx™ Drug-Eluting Coronary Stent System

    Abbott Australasia Pty Ltd

    Coronary Disease

    phase 3 other completed

    1 trial

  37. Zodasiran

    Arrowhead Pharmaceuticals Ireland Limited

    Homozygous Familial Hypercholesterolemia

    phase 3 small molecule active

    1 trial

  38. Zoledronic acid

    Novartis Pharmaceuticals

    Breast Cancer

    phase 3 small molecule completed

    1 trial

  39. Zoledronic acid

    Novartis Pharmaceuticals

    Osteoporosis

    phase 3 small molecule completed

    1 trial

  40. Zoledronic acid

    United Therapeutics Europe Ltd

    Osteoporosis

    phase 3 small molecule terminated

    1 trial

  41. Zolgensma 2 × 10^13 vector genomes/mL solution for infusion

    Novartis Pharmaceuticals

    Spinal Muscular Atrophy

    phase 3 small molecule active

    1 trial

  42. Zolpidem extended-release

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Addiction

    phase 3 small molecule completed

    1 trial

  43. Zometa 4 mg/100 ml solution for infusion

    Ningbo Cancer Hospital

    High grade osteosarcoma

    phase 3 small molecule active

    1 trial

  44. Zonisamide

    Eisai Co.,

    Epilepsy

    phase 3 small molecule completed

    1 trial

  45. [18F]-AlF-FAPI-74

    Disc Medicine

    Advanced gastric cancer

    phase 3 small molecule active

    1 trial

  46. [18F]-AlF-FAPI-74

    Disc Medicine

    Carcinoma of Unknown Primary

    phase 3 small molecule active

    1 trial

  47. [18F]-AlF-FAPI-74 for Cholangiocarcinoma

    Disc Medicine

    Cholangiocarcinoma

    phase 3 small molecule active

    1 trial

  48. [18F]MNI-659

    Pari Pharma GmbH

    Patients with symptomatic and pre-symptomatic Huntington's disease

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.